Lessons from clinical trials in surgical oncology: Time for a new paradigm?

被引:2
|
作者
van de Velde, CJH [1 ]
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
关键词
D O I
10.1016/S0959-8049(99)81620-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1200
引用
收藏
页码:S299 / S299
页数:1
相关论文
共 50 条
  • [31] Recruiting participants to cancer prevention clinical trials: Lessons from successful community oncology networks
    McKinney, Martha M.
    Weiner, Bryan J.
    Wang, Virginia
    ONCOLOGY NURSING FORUM, 2006, 33 (05) : 951 - 959
  • [32] Lessons from maraviroc clinical trials
    Troia-Cancio, Paolo
    Asmuth, David M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (06) : 649 - 651
  • [33] Lessons from controlled clinical trials
    Matteson, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 35 - 35
  • [34] Statistical Fragility of Surgical and Procedural Clinical Trials in Orthopaedic Oncology
    Forrester, Lynn Ann
    Jang, Eugene
    Lawson, Michelle M.
    Capi, Ana
    Tyler, Wakenda K.
    JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS, 2020, 4 (06):
  • [35] The Development of Investigator-Initiated Clinical Trials in Surgical Oncology
    McDonald, Hannah G.
    Cassim, Emily B.
    Harper, Megan M.
    Burke, Erin E.
    Marcinkowski, Emily F.
    Cavnar, Michael J.
    Pandalai, Prakash K.
    Kim, Joseph
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (01) : 13 - 25
  • [36] Trends in clinical trials in surgical oncology: Implications for outcomes research
    Guller, U
    Blumenstein, BA
    CLINICAL THERAPEUTICS, 2003, 25 (02) : 684 - 698
  • [37] Duration of and time to response in oncology clinical trials from the perspective of the estimand framework
    Weber, Hans-Jochen
    Corson, Stephen
    Li, Jiang
    Mercier, Francois
    Roychoudhury, Satrajit
    Sailer, Martin Oliver
    Sun, Steven
    Todd, Alexander
    Yung, Godwin
    PHARMACEUTICAL STATISTICS, 2024, 23 (01) : 91 - 106
  • [38] Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto, Chris H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (04) : 703 - 709
  • [39] Exploiting grid technologies for the simulation of clinical trials: the paradigm of in silico radiation oncology
    Athanaileas, Theodoros
    Menychtas, Andreas
    Dionysiou, Dimitra
    Kyriazis, Dimosthenis
    Kaklamani, Dimitra
    Varvarigou, Theodora
    Uzunoglu, Nikolaos
    Stamatakos, Georgios
    SIMULATION-TRANSACTIONS OF THE SOCIETY FOR MODELING AND SIMULATION INTERNATIONAL, 2011, 87 (10): : 893 - 910
  • [40] Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?
    Fu, Sherry
    Gerber, David E. E.
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) : 181 - +